MPN Clinical Trial updates from Geron and Promedior

Geron announces removal of Full Clinical Hold on Imetelstat The full clinical hold on Geron’s sole pipeline candidate, investigation new drug (IND), Imetelstat, has been lifted by the FDA.  The company does not intend to conduct further studies or develop imetelstat for the treatment of essential thrombocythemia (ET) or polycythemia vera (PV).  The development plan […]

MPN Clinical Trials Moving Forward

Two MPN Clinical Trials Progress – Phase 3 Polycythemia Vera Study and Phase 2 Myelofibrosis Study There are dozens of clinical trials at various stages of progression for Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis.  Some are in the recruiting stage, others still active and the balance have been completed.  Both of these trials will be […]

error: Content is protected !
Malcare WordPress Security